"Brain Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
Descriptor ID |
D001932
|
MeSH Number(s) |
C04.588.614.250.195 C10.228.140.211 C10.551.240.250
|
Concept/Terms |
Brain Neoplasms- Brain Neoplasms
- Neoplasms, Brain
- Brain Neoplasm
- Neoplasm, Brain
- Brain Tumors
- Brain Tumor
- Tumor, Brain
- Tumors, Brain
Brain Cancer- Brain Cancer
- Brain Cancers
- Cancer, Brain
- Cancers, Brain
- Malignant Neoplasms, Brain
- Brain Malignant Neoplasm
- Brain Malignant Neoplasms
- Malignant Neoplasm, Brain
- Cancer of Brain
- Cancer of the Brain
- Neoplasms, Brain, Malignant
- Brain Neoplasms, Malignant
- Brain Neoplasm, Malignant
- Malignant Brain Neoplasm
- Malignant Brain Neoplasms
Brain Tumor, Recurrent- Brain Tumor, Recurrent
- Brain Tumors, Recurrent
- Recurrent Brain Tumor
- Recurrent Brain Tumors
Malignant Primary Brain Tumors- Malignant Primary Brain Tumors
- Primary Malignant Brain Tumors
- Malignant Primary Brain Neoplasms
- Primary Malignant Brain Neoplasms
- Brain Neoplasms, Malignant, Primary
- Brain Neoplasms, Primary Malignant
Benign Neoplasms, Brain- Benign Neoplasms, Brain
- Benign Neoplasm, Brain
- Brain Benign Neoplasm
- Brain Benign Neoplasms
- Neoplasms, Brain, Benign
- Brain Neoplasms, Benign
- Benign Brain Neoplasm
- Benign Brain Neoplasms
- Brain Neoplasm, Benign
Brain Tumor, Primary- Brain Tumor, Primary
- Brain Tumors, Primary
- Primary Brain Tumor
- Primary Brain Tumors
- Neoplasms, Brain, Primary
- Brain Neoplasm, Primary
- Brain Neoplasms, Primary
- Primary Brain Neoplasm
- Primary Brain Neoplasms
|
Below are MeSH descriptors whose meaning is more general than "Brain Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Brain Neoplasms".
This graph shows the total number of publications written about "Brain Neoplasms" by people in this website by year, and whether "Brain Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 10 | 1 | 11 |
1996 | 12 | 1 | 13 |
1997 | 5 | 2 | 7 |
1998 | 8 | 2 | 10 |
1999 | 3 | 3 | 6 |
2000 | 14 | 1 | 15 |
2001 | 4 | 1 | 5 |
2002 | 9 | 2 | 11 |
2003 | 13 | 6 | 19 |
2004 | 15 | 2 | 17 |
2005 | 11 | 1 | 12 |
2006 | 6 | 1 | 7 |
2007 | 17 | 4 | 21 |
2008 | 20 | 3 | 23 |
2009 | 14 | 2 | 16 |
2010 | 35 | 2 | 37 |
2011 | 23 | 2 | 25 |
2012 | 32 | 1 | 33 |
2013 | 34 | 3 | 37 |
2014 | 37 | 6 | 43 |
2015 | 37 | 4 | 41 |
2016 | 30 | 2 | 32 |
2017 | 36 | 3 | 39 |
2018 | 31 | 4 | 35 |
2019 | 47 | 1 | 48 |
2020 | 27 | 4 | 31 |
2021 | 35 | 1 | 36 |
2022 | 27 | 3 | 30 |
2023 | 34 | 1 | 35 |
2024 | 26 | 8 | 34 |
2025 | 8 | 1 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Brain Neoplasms" by people in Profiles.
-
Global DNA methylation differences involving germline structural variation impact gene expression in pediatric brain tumors. Nat Commun. 2025 May 21; 16(1):4713.
-
G-quadruplex stabilizer CX-5461 effectively combines with radiotherapy to target a-thalassemia/mental retardation X-linked-deficient malignant glioma. Neuro Oncol. 2025 May 15; 27(4):932-947.
-
Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children's Oncology Group study. Neuro Oncol. 2025 May 15; 27(4):1092-1101.
-
Machine learning-based prognostic subgrouping of glioblastoma: A multicenter study. Neuro Oncol. 2025 May 15; 27(4):1102-1115.
-
IDH status dictates oHSV mediated metabolic reprogramming affecting anti-tumor immunity. Nat Commun. 2025 Apr 24; 16(1):3874.
-
An in vivo screen identifies NAT10 as a master regulator of brain metastasis. Sci Adv. 2025 Mar 28; 11(13):eads6021.
-
Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825. Neuro Oncol. 2025 Mar 07; 27(3):767-778.
-
Chimeric antigen receptor T-cell therapy in patients with malignant glioma-From neuroimmunology to clinical trial design considerations. Neuro Oncol. 2025 Feb 10; 27(2):352-368.
-
Targeting EPHB2/ABL1 restores antitumor immunity in preclinical models of ependymoma. Proc Natl Acad Sci U S A. 2025 Jan 28; 122(4):e2319474122.
-
Prolonged complete response to adjuvant tepotinib in a patient with newly diagnosed disseminated glioblastoma harboring mesenchymal-epithelial transition fusion. Oncologist. 2025 Jan 17; 30(1).